Bio-Matrix Scientific Group, Inc.
Bio-Matrix Scientific's Research Subsidiary, Entest BioMedical, Inc., Files Stem Cell Therapy Patent Application for Treatment of COPD
Published in Medical Device Law Weekly, September 6th, 2009
Bio-Matrix Scientific Group, Inc. (OTCBB: BMSN) announced its majority owned subsidiary, Entest BioMedical unit (OTCBB: ENTB), has filed a patent application for the use of adipose derived stem cells in the treatment of Chronic Obstructive Pulmonary Disease (COPD). BMSN is excited with the progress achieved by Entest BioMedical, Inc. (OTCBB: ENTB) in identifying diseases it believes will be treatable through Stem Cell Therapy.
Chronic Obstructive Pulmonary Disease is a major health disorder that appears to be treatable through adipose derived stem cell therapy. COPD is a group of lung inflammatory diseases which includes both emphysema and chronic obstructive bronchitis...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Law Weekly
More Articles from Medical Device Law Weekly
- Chromatography
Researchers from University of Nebraska, Department of Chemistry report details of new studies and findings in the area of chromatography - Dey, L.P.
Dey Issues Advisory - Abdominal Aortic Aneurysm
Research from K.A. Giles and colleagues provide new insights into abdominal aortic aneurysm - Acid Reflux Disease
Reports from University of Kansas, Medical Department advance knowledge in acid reflux disease - Acinar Cell Cancer
Research from Indiana University, Medical Department provide new insights into acinar cell cancer - Acne Vulgaris Therapy
New acne vulgaris therapy study findings have been reported from Seoul National University, Department of Dermatology - More from this issue of Medical Device Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
